Header Logo

Connection

REZA JOHN MEHRAN to Adjuvants, Immunologic

Back to Details
This is a "connection" page, showing publications REZA JOHN MEHRAN has written about Adjuvants, Immunologic.
REZA JOHN MEHRAN
Connection Strength
0.113
Adjuvants, Immunologic
  1. A Randomized Phase II Trial of Adjuvant Galinpepimut-S, WT-1 Analogue Peptide Vaccine, After Multimodality Therapy for Patients with Malignant Pleural Mesothelioma. Clin Cancer Res. 2017 Dec 15; 23(24):7483-7489.
    View in: PubMed
    Score: 0.113
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.